Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
- Hormonothérapie
Extract
A phase 2, randomized, open-label study of bosutinib administered in combination with exemestane versus exemestane alone as second line therapy in postmenopausal women with locally advanced or metastatic ER+/PgR+/ErbB2- breast cancer
Scientific Abstract
en cours d'intégration;